Home › Research › Topics › reduces
reduces
5 studies tagged reduces, dated 2002-05-01 to 2025-02-01. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- SSRIs reduce plasma tau and restore dorsal raphe metabolism in Alzheimer's disease 2025-02-01
- Aquaporin-4 reduces neuropathology in a mouse model of Alzheimer's disease by remodeling peri-plaque astrocyte structure 2019-05-08
- S100B Inhibitor Pentamidine Attenuates Reactive Gliosis and Reduces Neuronal Loss in a Mouse Model of Alzheimer's Disease 2015-07-29
Studies
5 studies carry this tag.
Date range
2002 to 2025
Top journals
- Acta neuropathologica communications 1
- Alzheimer's & dementia : the journal of the Alzheimer's Association 1
- BioMed research international 1
- Journal of Alzheimer's disease : JAD 1
- Journal of neurochemistry 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Long-term SSRI use may reduce the pathological presentation of AD but has variable effects on cognitive performance.
-
Redistribution of the water channel aquaporin-4 (AQP4) away from astrocyte endfeet and into parenchymal processes is a striking histological feature in mouse models of Alzheimer's disease (AD) and other neurological conditions with prominent astrogliosis.
-
Among the different signaling molecules released during reactive gliosis occurring in Alzheimer's disease (AD), the astrocyte-derived S100B protein plays a key role in neuroinflammation, one of the hallmarks of the disease.
-
Alzheimer's disease (AD) is the most common age-related neurodegenerative disorder.
-
Alzheimer's disease neuropathology is characterised by beta-amyloid plaques and neurofibrillary tangles.